Published: 2018-12-09

Articles

Do Prior Authorization Policies Discourage First-Line Antipsychotic Use in Patients Newly Discharged from a Hospitalization for Schizophrenia in Saskatchewan?

David F Blackburn, David Tran, Alex Crawley, Sarah Lynds, Anne Champagne, Lauren Bresee
Abstract 163 | PDF Downloads 103

Canada's Progress Toward an Orphan Drug Framework: 2014

Stuart MacLeod
Abstract 202 | PDF Downloads 96

An Orphan Drug Framework (ODF) for Canada

David K Lee, Barbara Wong
Abstract 419 | PDF Downloads 378

Redefining Cancer: A New Paradigm for Better and Faster Treatment Innovation

David J Stewart, Gerald Batist
Abstract 287 | PDF Downloads 133

A New Toolkit for Conducting Clinical Trials in Rare Disorders

Lusine Abrahamyan, Ivan R Diamond, Sindhu R Johnson, Brian M Feldman
Abstract 229 | PDF Downloads 195

A New Toolkit for Conducting Clinical Trials in Rare Disorders: Will This Dog Hunt?

Robert G Peterson, Stuart M MacLeod, Agnes V Klein
Abstract 148 | PDF Downloads 123

The Differential Diagnosis of Fetal Alcohol Spectrum Disorder

Tom Leibson, Gal Neuman, Albert E Chudley, Gideon Koren
Abstract 2302 | PDF Downloads 1926

Validation of the Photographic Method in Fetal Alcohol Spectrum Disorder Screening and Diagnosis

Marina Avner, Paul Henning, Gideon Koren, Irena Nulman
Abstract 497 | PDF Downloads 361